Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v5-FR
Language English French
Date Updated 2020-05-14 2020-05-13
Drug Identification Number 00038172 00038172
Brand name QUELICIN QUELICIN
Common or Proper name QUELICIN QUELICIN
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients SUCCINYLCHOLINE CHLORIDE SUCCINYLCHOLINE CHLORIDE
Strength(s) 20MG 20MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 25 x 10mL vial 25 x 10mL vial
ATC code M03AB M03AB
ATC description MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-05-08 2020-05-08
Actual start date
Estimated end date
Actual end date 2020-05-13 2020-05-13
Shortage status Resolved Actual shortage
Company comments
Health Canada comments